Target intelligence / Profile preview

Hepatitis C virus p7 ion channel (p7) (p7)

Target
p7
Molecular classification
Viroporin, Ion channel
01

Overview

The Hepatitis C virus p7 ion channel is a small, 63-amino acid hydrophobic protein that functions as a viroporin, essential for the production of infectious viral particles (UniProt: P26664). It oligomerizes into hexameric or heptameric complexes that form cation-selective channels within host cell membranes, particularly the endoplasmic reticulum and Golgi apparatus (PubMed: 23396147). While p7 is not required for viral genome replication, it plays a pivotal role in the late stages of the viral life cycle, including the assembly and maturation of virions (PubMed: 23408621). By acting as a proton channel, it helps to neutralize acidic compartments, thereby protecting the pH-sensitive viral glycoproteins from premature conformational changes or degradation (PubMed: 20862355). This protein is considered a viable therapeutic target, and several classes of inhibitors, such as amantadine and BIT225, have been identified to block its ion channel activity (PubMed: 20444935). However, the high genetic variability among HCV genotypes presents a significant challenge for the development of universal p7 inhibitors (PubMed: 24218191). Additionally, the potential for rapid emergence of resistance mutations necessitates the use of p7 inhibitors in combination with other direct-acting antivirals (PubMed: 24218191).

Other names
p7 proteinHCV p7p7 viroporinNon-structural protein 7
02

Mechanism of action

Inhibition of the p7 viroporin ion channel activity, which prevents the equilibration of pH in intracellular compartments and disrupts the assembly and release of infectious HCV progeny (PubMed: 20444935).

03

Biological functions

Viral assemblyViral releaseIon transportpH regulationMembrane permeability
04

Disease associations

InfectionHepatitis CLiver cirrhosisHepatocellular carcinoma
05

Safety considerations

Genotype-specific drug resistanceHigh genetic variabilityPotential off-target effects on host cell ion channelsLimited clinical efficacy of existing inhibitors
06

Interacting drugs

Amantadine

4 more in the full profile.

07

Biomarkers

HCV RNA viral loadAlanine aminotransferase (ALT)Aspartate aminotransferase (AST)

Beyond the preview

Go deeper on Hepatitis C virus p7 ion channel (p7) (p7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis C virus p7 ion channel (p7) (p7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call